The report focuses on the Autoimmune Drugs market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Autoimmune Drugs market.
Major Players in the Autoimmune Drugs market are:
Biogen
Takeda Pharmaceuticals
Amgen
Vertex Pharmaceuticals
AbbVie
Eisai
Sanofi
Antares Pharma
Can-Fite BioPharma
GSK
Eli Lilly
KaloBios Pharmaceuticals
F. Hoffmann-La Roche
Boehringer Ingelheim
Novartis
Johnson & Johnson
AstraZeneca
Lexicon Pharmaceuticals
Merck
Pfizer
Acorda Therapeutics
On the basis of types, the Autoimmune Drugs market is primarily split into:
Rheumatoid Arthritis (RA)
Multiple Sclerosis (MS)
Psoriasis
Inflammatory Bowel Disease (IBD)
Ankylosing Spondylitis (AS)
Systemic Lupus Erythematosus (SLE)
On the basis of applications, the market covers:
Hospital
Clinic
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Global Autoimmune Drugs Market Research Report 2022 - Market Size, Current Insights and Development Trends
Table of Content
1 Autoimmune Drugs Market Overview
1.1 Product Overview and Scope of Autoimmune Drugs Market
1.2 Autoimmune Drugs Market Segment by Type
1.2.1 Global Autoimmune Drugs Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Autoimmune Drugs Market Segment by Application
1.3.1 Autoimmune Drugs Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Autoimmune Drugs Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Autoimmune Drugs (2017-2029)
1.5.1 Global Autoimmune Drugs Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Autoimmune Drugs Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Autoimmune Drugs Industry
1.7 Impact of Carbon Neutrality on the Autoimmune Drugs Industry
2 Autoimmune Drugs Market Upstream and Downstream Analysis
2.1 Autoimmune Drugs Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Autoimmune Drugs Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles
3.1 Biogen
3.1.1 Biogen Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Autoimmune Drugs Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Takeda Pharmaceuticals
3.2.1 Takeda Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Autoimmune Drugs Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Amgen
3.3.1 Amgen Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Autoimmune Drugs Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Vertex Pharmaceuticals
3.4.1 Vertex Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Autoimmune Drugs Market Performance (2017-2022)
3.4.4 Business Overview
3.5 AbbVie
3.5.1 AbbVie Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Autoimmune Drugs Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Eisai
3.6.1 Eisai Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Autoimmune Drugs Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Sanofi
3.7.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Autoimmune Drugs Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Antares Pharma
3.8.1 Antares Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Autoimmune Drugs Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Can-Fite BioPharma
3.9.1 Can-Fite BioPharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Autoimmune Drugs Market Performance (2017-2022)
3.9.4 Business Overview
3.10 GSK
3.10.1 GSK Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Autoimmune Drugs Market Performance (2017-2022)
3.10.4 Business Overview
3.11 Eli Lilly
3.11.1 Eli Lilly Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Product Profiles, Application and Specification
3.11.3 Autoimmune Drugs Market Performance (2017-2022)
3.11.4 Business Overview
3.12 KaloBios Pharmaceuticals
3.12.1 KaloBios Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Product Profiles, Application and Specification
3.12.3 Autoimmune Drugs Market Performance (2017-2022)
3.12.4 Business Overview
3.13 F. Hoffmann-La Roche
3.13.1 F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Product Profiles, Application and Specification
3.13.3 Autoimmune Drugs Market Performance (2017-2022)
3.13.4 Business Overview
3.14 Boehringer Ingelheim
3.14.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Product Profiles, Application and Specification
3.14.3 Autoimmune Drugs Market Performance (2017-2022)
3.14.4 Business Overview
3.15 Novartis
3.15.1 Novartis Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Product Profiles, Application and Specification
3.15.3 Autoimmune Drugs Market Performance (2017-2022)
3.15.4 Business Overview
3.16 Johnson & Johnson
3.16.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Product Profiles, Application and Specification
3.16.3 Autoimmune Drugs Market Performance (2017-2022)
3.16.4 Business Overview
3.17 AstraZeneca
3.17.1 AstraZeneca Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Product Profiles, Application and Specification
3.17.3 Autoimmune Drugs Market Performance (2017-2022)
3.17.4 Business Overview
3.18 Lexicon Pharmaceuticals
3.18.1 Lexicon Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Product Profiles, Application and Specification
3.18.3 Autoimmune Drugs Market Performance (2017-2022)
3.18.4 Business Overview
3.19 Merck
3.19.1 Merck Basic Information, Manufacturing Base, Sales Area and Competitors
3.19.2 Product Profiles, Application and Specification
3.19.3 Autoimmune Drugs Market Performance (2017-2022)
3.19.4 Business Overview
3.20 Pfizer
3.20.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
3.20.2 Product Profiles, Application and Specification
3.20.3 Autoimmune Drugs Market Performance (2017-2022)
3.20.4 Business Overview
3.21 Acorda Therapeutics
3.21.1 Acorda Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.21.2 Product Profiles, Application and Specification
3.21.3 Autoimmune Drugs Market Performance (2017-2022)
3.21.4 Business Overview
4 Global Autoimmune Drugs Market Landscape by Player
4.1 Global Autoimmune Drugs Sales and Share by Player (2017-2022)
4.2 Global Autoimmune Drugs Revenue and Market Share by Player (2017-2022)
4.3 Global Autoimmune Drugs Average Price by Player (2017-2022)
4.4 Global Autoimmune Drugs Gross Margin by Player (2017-2022)
4.5 Autoimmune Drugs Market Competitive Situation and Trends
4.5.1 Autoimmune Drugs Market Concentration Rate
4.5.2 Autoimmune Drugs Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion
5 Global Autoimmune Drugs Sales, Revenue, Price Trend by Type
5.1 Global Autoimmune Drugs Sales and Market Share by Type (2017-2022)
5.2 Global Autoimmune Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Autoimmune Drugs Price by Type (2017-2022)
5.4 Global Autoimmune Drugs Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Autoimmune Drugs Sales, Revenue and Growth Rate of Rheumatoid Arthritis (RA) (2017-2022)
5.4.2 Global Autoimmune Drugs Sales, Revenue and Growth Rate of Multiple Sclerosis (MS) (2017-2022)
5.4.3 Global Autoimmune Drugs Sales, Revenue and Growth Rate of Psoriasis (2017-2022)
5.4.4 Global Autoimmune Drugs Sales, Revenue and Growth Rate of Inflammatory Bowel Disease (IBD) (2017-2022)
5.4.5 Global Autoimmune Drugs Sales, Revenue and Growth Rate of Ankylosing Spondylitis (AS) (2017-2022)
5.4.6 Global Autoimmune Drugs Sales, Revenue and Growth Rate of Systemic Lupus Erythematosus (SLE) (2017-2022)
6 Global Autoimmune Drugs Market Analysis by Application
6.1 Global Autoimmune Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Autoimmune Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Autoimmune Drugs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Autoimmune Drugs Consumption and Growth Rate of Hospital (2017-2022)
6.3.2 Global Autoimmune Drugs Consumption and Growth Rate of Clinic (2017-2022)
7 Global Autoimmune Drugs Sales and Revenue Region Wise (2017-2022)
7.1 Global Autoimmune Drugs Sales and Market Share, Region Wise (2017-2022)
7.2 Global Autoimmune Drugs Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
8 Global Autoimmune Drugs Market Forecast (2022-2029)
8.1 Global Autoimmune Drugs Sales, Revenue Forecast (2022-2029)
8.1.1 Global Autoimmune Drugs Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Autoimmune Drugs Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Autoimmune Drugs Price and Trend Forecast (2022-2029)
8.2 Global Autoimmune Drugs Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Autoimmune Drugs Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Autoimmune Drugs Sales and Revenue Forecast (2022-2029)
8.2.3 China Autoimmune Drugs Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Autoimmune Drugs Sales and Revenue Forecast (2022-2029)
8.2.5 India Autoimmune Drugs Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Autoimmune Drugs Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Autoimmune Drugs Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Autoimmune Drugs Sales and Revenue Forecast (2022-2029)
8.3 Global Autoimmune Drugs Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Autoimmune Drugs Revenue and Growth Rate of Rheumatoid Arthritis (RA) (2022-2029)
8.3.2 Global Autoimmune Drugs Revenue and Growth Rate of Multiple Sclerosis (MS) (2022-2029)
8.3.3 Global Autoimmune Drugs Revenue and Growth Rate of Psoriasis (2022-2029)
8.3.4 Global Autoimmune Drugs Revenue and Growth Rate of Inflammatory Bowel Disease (IBD) (2022-2029)
8.3.5 Global Autoimmune Drugs Revenue and Growth Rate of Ankylosing Spondylitis (AS) (2022-2029)
8.3.6 Global Autoimmune Drugs Revenue and Growth Rate of Systemic Lupus Erythematosus (SLE) (2022-2029)
8.4 Global Autoimmune Drugs Consumption Forecast by Application (2022-2029)
8.4.1 Global Autoimmune Drugs Consumption Value and Growth Rate of Hospital (2022-2029)
8.4.2 Global Autoimmune Drugs Consumption Value and Growth Rate of Clinic (2022-2029)
8.5 Autoimmune Drugs Market Forecast Under COVID-19
9 Industry Outlook
9.1 Autoimmune Drugs Market Drivers Analysis
9.2 Autoimmune Drugs Market Restraints and Challenges
9.3 Autoimmune Drugs Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Autoimmune Drugs Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Autoimmune Drugs Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Autoimmune Drugs Industry Development
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source
Global Autoimmune Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 29-Aug-2023 Price: US 3380 Onwards Pages: 101
Market Overview of Global Autoimmune Drugs market:
According to our latest research, the global Autoimmune Drugs market looks promising in the next 5 years. As of 2022, the global Autoimmune Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Autoimmune Drugs market......
Global Autoimmune Drugs Market Insights, Forecast to 2029
Published: 14-Aug-2023 Price: US 4900 Onwards Pages: 92
Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by chronic inflammatory processes that activate the innate immune system and the production of antibodies that destroy host tissues. These inflammatory processes can be caused by genetic or environmental ......
Global Systemic Lupus Erythematosus (SLE) Drugs Market Insights, Forecast to 2029
Published: 14-Aug-2023 Price: US 4900 Onwards Pages: 75
SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces autoantibodies, which attack and destroy healthy tissues in the body rather than foreign infectious agents. These autoantibodies cause inflammation, pain, and damage. It is also known as a disease of ......
Global Systemic Lupus Erythematosus (Sle) Drugs Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 11-Jul-2023 Price: US 3260 Onwards Pages: 130
The Systemic Lupus Erythematosus (Sle) Drugs market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Systemic Lupus Erythematosus (Sle) Drugs industry, and breaks down according to the type, application, and consumption area of Systemic Lupus Erythematosus (Sle) Drugs. The report also introduces players in the industry from the per......
Global Autoimmune Drugs Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 04-Jul-2023 Price: US 3260 Onwards Pages: 120
The Autoimmune Drugs market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Autoimmune Drugs industry, and breaks down according to the type, application, and consumption area of Autoimmune Drugs. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the lea......
Global Autoimmune Diseases Drugs Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 20-Jun-2023 Price: US 3260 Onwards Pages: 121
The Autoimmune Diseases Drugs market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Autoimmune Diseases Drugs industry, and breaks down according to the type, application, and consumption area of Autoimmune Diseases Drugs. The report also introduces players in the industry from the perspective of the industry chain and marketing ......
Global Systemic Lupus Erythematosus (SLE) Drugs Market Research Report 2023, Forecast to 2028
Published: 15-Mar-2023 Price: US 2680 Onwards Pages: 137
SLE is an autoimmune disease in which the immune system attacks its own tissues, causing widespread inflammation and tissue damage in the affected organs.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technologic......
Global Systemic Lupus Erythematosus (SLE) Drugs Professional Survey Report 2023, Forecast to 2028
Published: 15-Mar-2023 Price: US 3280 Onwards Pages: 108
SLE is an autoimmune disease in which the immune system attacks its own tissues, causing widespread inflammation and tissue damage in the affected organs.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technologic......
Global Systemic Lupus Erythematosus (SLE) Drugs Market Research Report 2023
Published: 07-Feb-2023 Price: US 2900 Onwards Pages: 67
SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces autoantibodies, which attack and destroy healthy tissues in the body rather than foreign infectious agents. These autoantibodies cause inflammation, pain, and damage. It is also known as a disease of ......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
